Unknown

Dataset Information

0

Disease-Modifying Therapy for Transthyretin Amyloidosis: Where to Start? Where to Stop?

ABSTRACT:

SUBMITTER: Fine NM 

PROVIDER: S-EPMC8299765 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Disease-Modifying Therapy for Transthyretin Amyloidosis: Where to Start? Where to Stop?

Fine Nowell M NM  

JACC. Case reports 20201118 13

Similar Datasets

Unknown Curcumin: A multi-target disease-modifying agent for late-stage transthyretin amyloidosis.
| S-EPMC4873750 | biostudies-literature
Unknown Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage.
| S-EPMC7755026 | biostudies-literature
Unknown Transthyretin Cardiac Amyloidosis: A Cardio-Orthopedic Disease.
| S-EPMC9775219 | biostudies-literature
Unknown Accessibility to Occupational Therapy Services for Hereditary Transthyretin Amyloidosis.
| S-EPMC9031487 | biostudies-literature
Unknown Transthyretin cardiac amyloidosis.
| S-EPMC9897687 | biostudies-literature
Unknown Transthyretin (TTR) cardiac amyloidosis.
| S-EPMC3501197 | biostudies-literature
Unknown Hereditary transthyretin amyloidosis overview.
| S-EPMC9780126 | biostudies-literature
Unknown Changing paradigm in the treatment of amyloidosis: From disease-modifying drugs to anti-fibril therapy.
| S-EPMC9808970 | biostudies-literature
Unknown Sixty years of experience with hereditary transthyretin amyloidosis: Insights from the Swedish transthyretin amyloidosis registry.
| S-EPMC12522535 | biostudies-literature
Unknown Molecular tweezers targeting transthyretin amyloidosis.
| S-EPMC3996111 | biostudies-literature